vimarsana.com

Latest Breaking News On - Company tearcare - Page 1 : vimarsana.com

Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery

MENLO PARK, Calif., April 29, 2024 Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the.

Sight Sciences (SGHT) Reports Results of the Three-Year Prospective GEMINI Trial

Sight Sciences (SGHT) Reports Results of the Three-Year Prospective GEMINI Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sight Sciences Announces The Results Of The Three-Year Prospective GEMINI Trial And The Cross-Over Phase Of The SAHARA RCT At The 2024 American Societ

Sight Sciences Announces The Results Of The Three-Year Prospective GEMINI Trial And The Cross-Over Phase Of The SAHARA RCT At The 2024 American Societ
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024 - Sight Sciences (NASDAQ:SGHT)

MENLO PARK, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative,

Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting

Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.